Statin Polyp Prevention Trial in Patients With Resected Colon Cancer.

Trial Profile

Statin Polyp Prevention Trial in Patients With Resected Colon Cancer.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 09 Mar 2015

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Colorectal cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 26 Sep 2013 M.D. Anderson Cancer Center record reports trial status as active, no longer recruiting.
    • 15 Aug 2012 New source identified and integrated (M.D. Anderson Cancer Center record, NSABP-P5).
    • 27 Jan 2012 Additional trial location (Canada) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top